Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q1 Adjusted EBITDA Up At SEK 8.8 Mln

April 24 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * STRONG GROWTH IN WARM PERFUSION AND PROGRESS IN THE
RESEARCH AND
DEVELOPMENT PORTFOLIO
    * Q1 NET SALES SEK 47.7 MILLION VERSUS SEK 42.5 MILLION YEAR
AGO
    * Q1 ADJ EBITDA SEK 8.8 MLN VS SEK 7.2 MLN YR AGO

Source text for Eikon:  ID:nWkr7d2pGx 
Further company coverage:  XVIVO.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Xvivo Perfusion AB

See all news